A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia

NCT00539084 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-05-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether the MicronJet microneedle device is effective for inducing rapid and painless local anesthesia prior to insertions of intravenous catheters.

Conditions

  • Local Anesthesia
  • Intradermal Injections

Interventions

DEVICE

MicronJet

The MicronJet is a microneedle injection device designed for intradermal delivery of drugs (i.e. delivery into the layers of the skin). In this study the MicronJet will be used to inject Lidocaine or Saline.

Sponsors & Collaborators

  • NanoPass Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Jacob Atsmon, MD · Head of the unit for Clinical Research at the Sourasky Medical Center, Tel Aviv, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-10-31
Completion
2007-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00539084 on ClinicalTrials.gov